Director, Haematology External Innovation (Early S&E)

Csl

Maidenhead

Hybrid

GBP 180,000 - 240,000

Full time

11 days ago

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

CSL Behring is expanding its external innovation capability, seeking a Director of Search & Evaluation to shape the Haematology portfolio. The role leads strategic sourcing and evaluation of early assets from preclinical to Phase 1, developing partnering strategies and driving transactions in collaboration with Business Development.

Based in a hybrid model onsite at Maidenhead (UK) with other hub sites, you will lead the Therapeutic Area Leadership Team, build a robust external pipeline, and

Qualifications

  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Must have deep scientific expertise in Haematology.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.

Responsibilities

  • Lead strategic sourcing and evaluation of external innovation opportunities in Haematology.
  • Coordinate due diligence and deal negotiations for preclinical to Phase 1 assets.
  • Develop early partnering strategies and onboarding approaches for priority assets.
  • Drive cross-functional due diligence with scientific, regulatory, and commercial assessments.
  • Represent CSL externally at conferences and build biotech and academic partnerships.

Skills

External innovation
Search & Evaluation
Business development
Biopharma
Haematology

Education

Advanced degree (PhD/MD or equivalent)

Job description

CSL Behring is expanding its external innovation capability, seeking a Director of Search & Evaluation to shape the Haematology portfolio. The role leads strategic sourcing and evaluation of early assets from preclinical to Phase 1, developing partnering strategies and driving transactions in collaboration with Business Development.

Based in a hybrid model onsite at Maidenhead (UK) with other hub sites, you will lead the Therapeutic Area Leadership Team, build a robust external pipeline, and

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Search & Evaluation Early Ta Lead (Haem)
Director, Search & Evaluation Early Ta Lead (Haem)

Csl • Maidenhead

Hybrid
GBP 180,000 - 240,000
Senior Director, Immunology S&E: Late-Stage Partnerships
Senior Director, Immunology S&E: Late-Stage Partnerships

CSL • Maidenhead

Hybrid
GBP 180,000 - 240,000
Senior Director, Search & Evaluation Late TA Lead, Immunology
Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL • Maidenhead

Hybrid
GBP 180,000 - 240,000
Executive Director, External Hematology-Oncology Innovation
Executive Director, External Hematology-Oncology Innovation

Bristol Myers Squibb • Cambourne

Hybrid
GBP 199,000 - 242,000
Wellbeing support
Retirement benefits
Insurance
Global Clinical Scientist Lead - Hematology (Hybrid)
Global Clinical Scientist Lead - Hematology (Hybrid)

CSL • Maidenhead

Hybrid
GBP 141,000 - 166,000
Director (m/f/x), Global Market Access – Inline Haematology
Director (m/f/x), Global Market Access – Inline Haematology

CSL • Thatcham

Remote
GBP 140,000 - 190,000
Global Market Access Director — Inline Haematology
Global Market Access Director — Inline Haematology

CSL • Thatcham

Remote
GBP 140,000 - 190,000
Executive Director, Immunology External Innovation
Executive Director, Immunology External Innovation

Bristol Myers Squibb • Cambourne

On-site
GBP 200,000 - 242,000
Comprehensive benefits
Principal Clinical Scientist, Clinical Development - Hematology Research Development & Sciences Clinical Sciences CSL Behring Maidenhead, England, United Kingdom R-291638 Posted on November 3, 2026
Principal Clinical Scientist, Clinical Development - Hematology Research Development & Sciences Clinical Sciences CSL Behring Maidenhead, England, United Kingdom R-291638 Posted on November 3, 2026

CSL Limited • Maidenhead

Hybrid
GBP 168,000 - 199,000
Director, Vaccine Portfolio & External Partnerships
Director, Vaccine Portfolio & External Partnerships

Csl • Maidenhead

On-site
GBP 164,000 - 221,000